Led by CEO Benjamin Nazarian and based in Los Angeles, Therabody develops wellness technology products and content embraced by medical, sports, and beauty communities as well as consumers. Its flagship product line includes Theragun percussive devices and proprietary technologies that leverage biometrics for personalized real-time therapies. The company operates company-owned retail stores and Reset® whole-body wellness and recovery centers, and its products are available in more than 60 countries. Therabody recently launched eight new products expanding into whole-body wellness, including a new Theragun PRO, Theragun mini, and SmartGoggles™. SmartGoggles™ pair with TheraMind® sound therapy via the Therabody App and include a smart sensor that personalizes treatment to help lower heart rate and reduce stress and anxiety. The company plans to continue investing in innovation across hardware, software, services (including Reset), and digital content. Therabody commercialized the Theragun percussive massage device and has since expanded into an ecosystem of recovery and wellness products, including a Smart Percussive Therapy line, a Therabody app, and a USDA-certified CBD line (TheraOne). The company says it has been profitable since its first fully operational year in 2017, grew its profits more than 30x since 2017, and tripled overall revenue in 2020 versus the prior year. Therabody has expanded internationally to more than 60 countries and maintains offices in Shanghai, London, and Dublin, and has increased retail distribution from 40 U.S. stores to roughly 10,000 retail doors globally. The company has been active on product and IP development (126 patents issued, 138 pending) and in M&A, acquiring RP Sports and its RecoveryPump pneumatic compression technology in November 2020. With the new capital the company intends to accelerate research and development of new products and services and to continue heavy investment in international expansion, with plans to enter 10 new countries by 2022. Therabody positions its products for use by professional teams, medical professionals, and consumers for training, recovery, injury prevention, and treatment of pain and chronic ailments.

Total raised

$165M

Funding rounds

2

Latest round

Equity

Latest activity

Sep 2022